Over 20 million Americans have diabetes. As many as 40 million may have pre-diabetes. Controlling blood sugar is key to preventing the complications of this widespread metabolic disorder. But recent headlines have a lot of people worried that their medicine might be causing some of the very problems the drugs are supposed to prevent.
An old-fashioned pain reliever may offer a surprising new way to control blood sugar without putting people at risk of heart failure. But will doctors prescribe a drug that has been around for more than 100 years?
Guests: John B. Buse, MD, Chief of Endocrinology, UNC-CH School of Medicine and Director of the UNC Diabetes Care Center. He is also President-elect of the American Diabetes Association.
Steven E. Shoelson, MD, PhD, Professor of Medicine at Harvard University and Section Head of Cellular and Molecular Research at the Joslin Diabetes Center.
Allison B. Goldfine, MD, Assistant Director for Clinical Research and Investigator at the Joslin Diabetes Center.
Their clinical trial can be contacted at www.tinsal-t2d.org.
